Evidence map›Paper›PMID 24718373›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.

Michael A P Bloomfield, Fiona Pepper, Alice Egerton, Arsime Demjaha, Gianpaolo Tomasi, Elias Mouchlianitis, Levi Maximen, Mattia Veronese, Federico Turkheimer, Sudhakar Selvaraj and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Similarities and Differences in Neurobiology.Advances in experimental medicine and biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Michael A P Bloomfield1] Psychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK [2] Department of Psychosis Studies, Institute of Psychiatry, King's College London (King's Health Partners), De Crespigny Park, London, UK.
Fiona Pepper1] Psychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK [2] Department of Psychosis Studies, Institute of Psychiatry, King's College London (King's Health Partners), De Crespigny Park, London, UK.
Alice Egerton1] Psychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK [2] Department of Psychosis Studies, Institute of Psychiatry, King's College London (King's Health Partners), De Crespigny Park, London, UK.
Arsime Demjaha1] Psychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK [2] Department of Psychosis Studies, Institute of Psychiatry, King's College London (King's Health Partners), De Crespigny Park, London, UK.
Gianpaolo TomasiMedical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK.
Elias MouchlianitisPsychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK.
Levi MaximenHammersmith Imanet Limited, Hammersmith Hospital, London, UK.
Mattia VeroneseDepartment of Neuroimaging, Institute of Psychiatry, King's College London (King's Health Partners), London, UK.
Federico TurkheimerDepartment of Neuroimaging, Institute of Psychiatry, King's College London (King's Health Partners), London, UK.
Sudhakar SelvarajPsychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK.
Oliver D Howes1] Psychiatric Imaging Group, Mansfield Building, Medical Research Council Clinical Sciences Centre, Institute of Clinical Sciences, Hammersmith Hospital, Imperial College London, London, UK [2] Department of Psychosis Studies, Institute of Psychiatry, King's College London (King's Health Partners), De Crespigny Park, London, UK.
Medical Research Council · GBHammersmith Hospital · GBKings Health Partners · GBImperial College London · GBKing's College London · GB

Funding

Medical Research Council G0700995Medical Research Council G1100809Medical Research Council MC-A656-5QD30Medical Research Council MC_U120097115
6 · The paper itself

Abstract

Tobacco addiction is a global public health problem. Addiction to tobacco is thought to involve the effects of nicotine on the dopaminergic system. Only one study has previously investigated dopamine synthesis capacity in cigarette smokers. This study, exclusively in male volunteers, reported increased dopamine synthesis capacity in heavy smokers compared with non-smokers. We sought to determine whether dopamine synthesis capacity was elevated in a larger sample of cigarette smokers that included females. Dopamine synthesis capacity was measured in 15 daily moderate smokers with 15 sex- and age-matched control subjects who had never smoked tobacco. Dopamine synthesis capacity (indexed as the influx rate constant K(i)(cer)) was measured with positron emission tomography and 3,4-dihydroxy-6-[(18)F]-fluoro-l-phenylalanine. There was no significant group difference in dopamine synthesis capacity between smokers and non-smoker controls in the whole striatum (t28=0.64, p=0.53) or any of its functional subdivisions. In smokers, there were no significant relationships between the number of cigarettes smoked per day and dopamine synthesis capacity in the whole striatum (r=-0.23, p=0.41) or any striatal subdivision. These findings indicate that moderate smoking is not associated with altered striatal dopamine synthesis capacity.

Indexed as

AdultCase-Control StudiesCorpus StriatumDihydroxyphenylalanineDopamineFemaleHumansMalePositron-Emission TomographyRadiopharmaceuticalsSmokingSurveys and QuestionnairesTobacco Use DisorderDihydroxyphenylalanineDopaminefluorodopa F 18Radiopharmaceuticals

Identifiers

PMID24718373
PMCPMC4138749
OpenAlexW2075511206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.